Cambridge Research Biochemicals (CRB), a specialist life science research tool provider based in the North East of England, today launches its brand new, much improved, user friendly website. The site, which has been re-designed and re-launched for improved customer usability and experience and incorporates new content and design features, is based around the WordPress system…. Read more »
Cyclic peptides are of increasing interest in drug discovery projects because the cyclic structure allows pharmacophores to be arranged in an optimal conformation for receptor binding and/or because cyclic peptides are resistant to peptidases and hence more stable making them more potent and longer acting.
Cambridge Research Biochemicals® (CRB), a British company specialising in custom peptides and bespoke antibodies for the Pharmaceutical industry and for medical research, today announced the release of its new Discovery Peptides® catalogue.
Having delighted customers with the highest quality peptides and antibodies during its 35 years of expertise in the life science industry, has announced the revival of its peptide catalogue.
25th July 2015 will see Cambridge Research Biochemicals celebrate 35 years of supply of its products and services to eminent research scientists across the globe. Furthermore, Directors Emily Humphrys and Alison White also celebrate 25 years and 30 years respectively at CRB. This anniversary piece also honours CRB’s longest standing customer and world renowned Scientist… Read more »
Cambridge Research Biochemicals (CRB) will continue to supply The Medical Research Council (MRC) with custom-synthesised peptides and bespoke polyclonal and monoclonal antibodies for a further 12 months as a valued preferred supplier under a new pricing agreement.